Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "Shionogi"

SHIONOGI : Research Conducted at Shionogi & Co. Ltd. Has Provi...

Research Conducted at Shionogi & Co. Ltd. Has Provided New Information about Antisense Technology (Pharmacokinetic-pharmacodynamic modeling for reduction of hepatic apolipoprotein B mRNA and plasma total cholesterol after administration of ...) ... 4 Traders, 1 week ago

AUROBINDO PHARMA : IN A LEGAL TANGLE

Aurobindo Pharma Ltd is in a legal battle with Shionogi of Japan . The Japanese drug firm has filed a suit against Aurobindo Pharma to stop it from producing the generic version of its drug Doribax. Dirobax is used for anti bacterial ...
 4 Traders3 weeks ago Japanese Co Drags APL to US Court  New Indian Express1 month ago Aurobindo Pharma in a legal tangle  Financial Chronicle1 month ago

New and Generic Drug Approvals: Osphena

Drug Name(s) OSPHENA FDA Application No. (NDA) 203505 Active Ingredient(s) OSPEMIFENE Company SHIONOGI INC Original Approval or Tentative Approval Date February 26, 2013 Chemical Type ...
 U.S. Food and Drug Administration4 days ago New and Generic Drug Approvals: Ponstel  U.S. Food and Drug Administration1 month ago

Shionogi to Announce Appointment of Directors, Corporate Officers and Corporate Reorganization

 Noodls6 days ago Egalet Appoints As Chief Commercial Officer  BioSpace1 month ago Egalet Appoints Deanne F. Melloy as Chief Commercial Officer  SearchBug1 month ago Press Release: Egalet Appoints Deanne F. Melloy as Chief Commercial Officer  iMarketReports1 month ago
[x]  

Shionogi Down 4.9% After Booking Profit Falls — Market Talk

0510 GMT [Dow Jones] Drug maker Shionogi & Co. (4507.TO) is down 4.9% at Y3,375 after its 3Q results showed nine-month declines of 8.2% in sales and 26.1% in operating profits. Nevertheless, the results still achieved nearly half of the firm's 2H ...
 iMarketReports3 weeks ago

Antibiotics Currently in Clinical Development

Cubist Pharmaceuticals Oxazolidinone Yes Approved for: acute bacterial skin and skin structure infections; other potential indications: hospital- acquired bacterial pneumonia/ventilator- acquired bacterial pneumonia Dalbavancin (Dalvance) ...
 The Pew Charitable Trusts3 days ago
Citybizlist

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The ' report is the most comprehensive study of the market of drugs being developed by the top pharmaceutical companies for rare diseases. The focus of this study is primarily to uncover several initiatives currently underway to harness the ...
 Global Information Inc3 days ago Aegerion completes acquisition of Myalept from AstraZeneca  Pharmaceutical Business Review1 month ago Aegerion Pharma completes Myalept injection acquisition  PharmaBiz1 month ago Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog  Yahoo! Finance1 month ago
[x]  

Japan Pharma Outlook 2015: 2015 -Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating their domestic (and thus overseas) ...
 Global Information Inc4 days ago

Perennial Allergic Rhinitis Therapeutics Pipeline Review 2015

Research and Markets (http://www.researchandmarkets.com/research/mxpgxb/perennial) has announced the addition of the "Perennial Allergic Rhinitis - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on ...
 Individual.com5 days ago Seasonal Allergic Rhinitis Pipeline Review 2015 - Analysis of 9 Companies & 9 Drug Profiles  Individual.com5 days ago Research and Markets: Perennial Allergic Rhinitis Therapeutics Pipeline Review 2015  Green Technology5 days ago Research and Markets: Seasonal Allergic Rhinitis Pipeline Review 2015 - Analysis of 9 Companies & 9 Drug Profiles  Morningstar.com5 days ago
[x]  

SHIRE PLC - 10-K - : Management's discussion and analysis of financial condition and results of operations

The following discussion should be read in conjunction with the Company's consolidated financial statements contained in Part IV in this Annual Report on Form 10-K. Overview The Company has grown both organically and through acquisition, ...
 Pharmacy Choice6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Shionogi
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less